Paper Details

  1. Home
  2. Paper Details

Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities.

Author: MaltezosStefanos, PaliokostaElena, ThomsonAlex, XenitidisKiriakos

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Attention deficit hyperactivity disorder (ADHD) is increasingly recognized in people with intellectual disability (ID), but treating ADHD in this population hasn't been well-studied. Risperidone has been used to treat ADHD in people with ID, but its effectiveness is unclear.
Paper Details　
Original Abstract of the Article :
Attention deficit hyperactivity disorder (ADHD) is increasingly recognised as occurring in people with intellectual disability (ID), although treatment of ADHD in this population has not ben tested widely. Risperidone has been used to treat ADHD in people with ID, although the evidence for its effec...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387848/

データ提供：米国国立医学図書館（NLM）

Addressing ADHD in Individuals with Intellectual Disabilities

The field of neurodevelopmental disorders is constantly evolving, with new research shedding light on the complexities of these conditions. This study focuses on the often overlooked challenges of treating attention deficit hyperactivity disorder (ADHD) in individuals with intellectual disabilities (ID), a population that has historically received limited attention in ADHD research.

Risperidone: A Potential Solution for ADHD in Individuals with ID

The study examines the use of risperidone for treating ADHD in individuals with ID, acknowledging the lack of robust evidence on its effectiveness. While further research is needed to definitively establish its efficacy, this study provides valuable insights into potential treatment options for this underserved population.

The Importance of Research in Neurodevelopmental Disorders

This study underscores the critical need for research into the complexities of neurodevelopmental disorders, particularly in underserved populations like individuals with ID. The findings highlight the importance of exploring effective treatment options for ADHD in this population, which often faces significant challenges in managing symptoms.

Dr. Camel's Conclusion

This study shines a light on the challenges of treating ADHD in individuals with ID. The authors highlight the need for further research to develop effective treatment strategies for this often overlooked population. Their findings provide a starting point for understanding the complexities of ADHD in individuals with ID and encourage continued research to find effective solutions for this underserved group.

Date :
  1. Date Completed 2009-06-23
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19370667

DOI: Digital Object Identifier

PMC7387848

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.